- Home
- DXR vs CUBA Comparison
DXR vs CUBA Comparison
Compare DXR & CUBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXR
- CUBA
- Stock Information
- Founded
- DXR 1970
- CUBA 1992
- Country
- DXR United States
- CUBA United States
- Employees
- DXR N/A
- CUBA N/A
- Industry
- DXR Medical/Dental Instruments
- CUBA Investment Managers
- Sector
- DXR Health Care
- CUBA Finance
- Exchange
- DXR Nasdaq
- CUBA Nasdaq
- Market Cap
- DXR 36.4M
- CUBA 39.0M
- IPO Year
- DXR N/A
- CUBA N/A
- Fundamental
- Price
- DXR $7.30
- CUBA $2.62
- Analyst Decision
- DXR Strong Buy
- CUBA
- Analyst Count
- DXR 1
- CUBA 0
- Target Price
- DXR $25.00
- CUBA N/A
- AVG Volume (30 Days)
- DXR 4.8K
- CUBA 93.9K
- Earning Date
- DXR 01-01-0001
- CUBA 01-01-0001
- Dividend Yield
- DXR N/A
- CUBA 20.83%
- EPS Growth
- DXR 86.16
- CUBA N/A
- EPS
- DXR 0.11
- CUBA N/A
- Revenue
- DXR $119,714.00
- CUBA N/A
- Revenue This Year
- DXR N/A
- CUBA N/A
- Revenue Next Year
- DXR N/A
- CUBA N/A
- P/E Ratio
- DXR $66.24
- CUBA N/A
- Revenue Growth
- DXR N/A
- CUBA N/A
- 52 Week Low
- DXR $6.55
- CUBA $2.25
- 52 Week High
- DXR $10.00
- CUBA $4.14
- Technical
- Relative Strength Index (RSI)
- DXR 44.11
- CUBA 60.66
- Support Level
- DXR $7.19
- CUBA $2.43
- Resistance Level
- DXR $7.74
- CUBA $2.70
- Average True Range (ATR)
- DXR 0.41
- CUBA 0.09
- MACD
- DXR -0.02
- CUBA 0.02
- Stochastic Oscillator
- DXR 27.40
- CUBA 71.43
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
About CUBA Herzfeld Caribbean Basin Fund Inc. (The)
Herzfeld Caribbean Basin Fund Inc operates as a closed-end management investment company. The company's investment objective is to obtain long-term capital appreciation. The firm offers customized discretionary account management and fund management services to individual and institutional investors. The fund invests in equity and equity-linked securities of public and private companies, including United States-based companies, whose securities are traded principally on a stock exchange in a Caribbean Basin Country. The fund's revenue source is through the dividends it receives. Its investments are geographically allocated in the United States followed by Mexico, Puerto Rico, and other countries.